KARI KOBAYASHI: Open Payments
NPI 1972999456 · HILLSBORO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 24 payments from 8 companies in 2025. Trend: 2023 $858 · 2024 $682 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $363 |
| UCB, Inc. | 7 | $177 |
| Lilly USA, LLC | 2 | $138 |
| LEO Pharma Inc. | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| ABBVIE INC. | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
Products named: TREMFYA, Bimzelx, EBGLYSS, ANZUPGO, Rhapsido, SKYRIZI, DUPIXENT, TALTZ.
Industry payments across OR — which companies pay providers there.
